| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.044 | 0.8 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.0086 | 0.8 |